These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


170 related items for PubMed ID: 9860410

  • 1. Acute effects of transjugular intrahepatic portosystemic stent-shunt (TIPSS) procedure on renal blood flow and cardiopulmonary hemodynamics in cirrhosis.
    Stanley AJ, Redhead DN, Bouchier IA, Hayes PC.
    Am J Gastroenterol; 1998 Dec; 93(12):2463-8. PubMed ID: 9860410
    [Abstract] [Full Text] [Related]

  • 2. Systemic and regional changes in plasma endothelin following transient increase in portal pressure.
    Kapoor D, Redhead DN, Hayes PC, Webb DJ, Jalan R.
    Liver Transpl; 2003 Jan; 9(1):32-9. PubMed ID: 12514771
    [Abstract] [Full Text] [Related]

  • 3. [Influence of transjugular intrahepatic portosystemic stent shunts on portal and systemic hemodynamics of patients with portal hypertension].
    Wu X, Li J, Cao J, Wu X, Ni X.
    Zhonghua Wai Ke Za Zhi; 1998 Jun; 36(6):342-4. PubMed ID: 11825406
    [Abstract] [Full Text] [Related]

  • 4. Transjugular intrahepatic portosystemic shunt: short-term and long-term effects on hepatic and systemic hemodynamics in patients with cirrhosis.
    Lotterer E, Wengert A, Fleig WE.
    Hepatology; 1999 Mar; 29(3):632-9. PubMed ID: 10051460
    [Abstract] [Full Text] [Related]

  • 5. [Clinical results and hemodynamic changes of portal venous system in transjugular intrahepatic portosystemic stent shunt].
    Wu X, Cao J, Wu X.
    Zhonghua Wai Ke Za Zhi; 1996 May; 34(5):303-6. PubMed ID: 9387710
    [Abstract] [Full Text] [Related]

  • 6. Pulmonary hypertension after transjugular intrahepatic portosystemic shunt: effects on right ventricular function.
    Van der Linden P, Le Moine O, Ghysels M, Ortinez M, Devière J.
    Hepatology; 1996 May; 23(5):982-7. PubMed ID: 8621179
    [Abstract] [Full Text] [Related]

  • 7. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
    Angeli P, Volpin R, Piovan D, Bortoluzzi A, Craighero R, Bottaro S, Finucci GF, Casiglia E, Sticca A, De Toni R, Pavan L, Gatta A.
    Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Predictors of mortality and stenosis after transjugular intrahepatic portosystemic shunt.
    Russo MW, Jacques PF, Mauro M, Odell P, Brown RS.
    Liver Transpl; 2002 Mar; 8(3):271-7. PubMed ID: 11910573
    [Abstract] [Full Text] [Related]

  • 11. Covered transjugular intrahepatic portosystemic stents maintain lower portal pressure and require fewer reinterventions than uncovered stents.
    Ockenga J, Kroencke TJ, Schuetz T, Plauth M, Kasim E, Petersein J, Schmidt HH, Lochs H.
    Scand J Gastroenterol; 2004 Oct; 39(10):994-9. PubMed ID: 15513340
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites.
    Wong W, Liu P, Blendis L, Wong F.
    Am J Med; 1999 Mar; 106(3):315-22. PubMed ID: 10190381
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Reduction in renal blood flow following acute increase in the portal pressure: evidence for the existence of a hepatorenal reflex in man?
    Jalan R, Forrest EH, Redhead DN, Dillon JF, Hayes PC.
    Gut; 1997 May; 40(5):664-70. PubMed ID: 9203948
    [Abstract] [Full Text] [Related]

  • 17. Restoration of liver function and portosystemic pressure gradient after TIPSS and late TIPSS occlusion.
    Maedler U, Hansmann J, Duex M, Noeldge G, Sauer P, Richter GM.
    Cardiovasc Intervent Radiol; 2002 May; 25(2):148-51. PubMed ID: 11901436
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Endotoxin and tumor necrosis factor-receptor levels in portal and hepatic vein of patients with alcoholic liver cirrhosis receiving elective transjugular intrahepatic portosystemic shunt.
    Trebicka J, Krag A, Gansweid S, Appenrodt B, Schiedermaier P, Sauerbruch T, Spengler U.
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1218-25. PubMed ID: 21971377
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.